018 — Memphis, Tennessee

018 is a clinical research site located in Memphis, Tennessee, United States.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

018 has participated in 1 clinical trials.

Therapeutic areas: Advanced Parkinson's Disease.

Sponsors: UCB Pharma.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 018?

018 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 018 conducted?

018 has 1 clinical trials on record. Their work covers Advanced Parkinson's Disease.

Is 018 accredited by Crixeo Health?

018 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 018?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.